Evidence map›Paper›PMID 10558858›Full record

ArticleBiochemical and biophysical research communications1999

Identification and characterization of a transcriptional silencer upstream of the human BRCA2 gene.

C Sharan, N M Hamilton, A K Parl, P K Singh, G Chaudhuri

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. SNP located in anThe British journal of ophthalmology · 2019
    Article
  3. Non-Coding Variants inCancers · 2018
    Review
  4. Article
  5. Retroelements and their impact on genome evolution and functioning.Cellular and molecular life sciences : CMLS · 2009
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

C SharanDivision of Biomedical Sciences, Department of Microbiology, Meharry Medical College, Nashville, Tennessee, 37208, USA.
N M Hamilton
A K Parl
P K Singh
G Chaudhuri
Meharry Medical College · US

Funding

MINORITY PREDOCTORAL FELLOWSHIP PROGRAMF31CA079035 · NCI · MEHARRY MEDICAL COLLEGE · PI HAMILTON, NALO M · 1998 to 2001
$52k
TRANSLATIONAL RESEARCH PROGRAMP30CA049095 · NCI · CHARLES R. DREW UNIVERSITY OF MED &SCI · 1988 to 1996
–
NCI NIH HHS 1F31CA79035-01NCI NIH HHS F31 CA079035NCI NIH HHS P30CA4909509S1NCRR NIH HHS SG12RR303412
6 · The paper itself

Abstract

Expression of the breast cancer susceptibility tumor-suppressor protein BRCA2, a protein potentially involved in DNA recombination repair, is tightly regulated throughout development. We have identified a transcriptional silencer at the distal end of the human BRCA2 gene promoter. This silencer is involved in the negative regulation of the expression of this gene in breast cell lines tested but not in HeLa or HepG2 cells. The 221-base-pair silencer region is characterized by a full-length Alu-repeat. Presence of specific BRCA2 silencer-binding proteins in the breast cell extracts indicates the potential regulation of BRCA2 gene expression by these proteins.

Indexed as

Genes, Tumor SuppressorSpermatozoaAlu ElementsAmino Acid SequenceBase SequenceBRCA2 ProteinBreastBreast NeoplasmsCell LineDNADNA-Binding ProteinsDNA PrimersFemaleGene Expression Regulation, NeoplasticHeLa CellsHumansBRCA2 ProteinDNADNA-Binding ProteinsDNA PrimersNeoplasm Proteinssperm Alu-binding protein, humanTranscription Factors

Identifiers

PMID10558858
PMCPMC3100288
OpenAlexW2093841541

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.